Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $37.45B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $2.87B | 7.7% |
| Business Acquisitions | $31.90B | 85.2% |
| Working Capital | $234.0M | 0.6% |
| Net Cash Flow | $2.45B | 6.5% |